Your browser doesn't support javascript.
loading
Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma.
Fujita, Misuzu; Kusumoto, Shigeru; Ishii, Itsuko; Iwata, Tadashi; Fujisawa, Takehiko; Sugiyama, Masaya; Hata, Akira; Mizokami, Masashi.
Afiliación
  • Fujita M; Department of Health Research, Chiba Foundation for Health Promotion and Disease Prevention, 32-14, Shinminato, Mihama-ku, Chiba, Chiba, 261-0002, Japan. mi-hujita@kenko-chiba.or.jp.
  • Kusumoto S; Genome Medical Science Project, National Center for Global Health and Medicine, 1-7-1, Kounodai, Ichikawa, Chiba, 272-8516, Japan. mi-hujita@kenko-chiba.or.jp.
  • Ishii I; Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan. mi-hujita@kenko-chiba.or.jp.
  • Iwata T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Fujisawa T; Division of Pharmacy, Chiba University Hospital, Chiba, Chiba, Japan.
  • Sugiyama M; Department of Medical Practice, The University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
  • Hata A; Department of Health Research, Chiba Foundation for Health Promotion and Disease Prevention, 32-14, Shinminato, Mihama-ku, Chiba, Chiba, 261-0002, Japan.
  • Mizokami M; Genome Medical Science Project, National Center for Global Health and Medicine, 1-7-1, Kounodai, Ichikawa, Chiba, 272-8516, Japan.
Sci Rep ; 12(1): 7365, 2022 05 05.
Article en En | MEDLINE | ID: mdl-35513395
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Virus de la Hepatitis B Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Virus de la Hepatitis B Tipo de estudio: Guideline / Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: Japón